Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
第一作者:
Grace,Li
第一单位:
Oxford Vaccine Group, Department of Paediatrics Centre for Vaccinology and Tropical Medicine, Churchill Hospital, Oxford, UK.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);抗体, 病毒(Antibodies, Viral);儿童(Child);双盲法(Double-Blind Method);人类(Humans);免疫球蛋白G(Immunoglobulin G);脑膜炎双球菌菌苗(Meningococcal Vaccines);单盲法(Single-Blind Method)
DOI
10.1016/S0140-6736(22)00770-X
PMID
35691324
发布时间
2022-12-17
- 浏览1
Lancet (London, England)
2212-2225页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



